$1.62 Billion Forecast for Exosome Diagnostic And Therapeutic Market by 2029, Backed by Demand and Innovation
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Key Projections for the CAGR of the Exosome Diagnostic And Therapeutic Market Size From 2025 to 2034?
In recent times, there has been a significant expansion in the exosome diagnostic and therapeutic market size. A growth projection shows that it will rise from $0.47 billion in 2024 to an estimated $0.6 billion by 2025, a compound annual growth rate (CAGR) of 29.3%. This historic growth can be credited to various factors such as advancements in biological research, the advent of precision medicine, innovations in biomedical imaging, advancements in cancer research and oncology, and investment influx into the healthcare sector.
The market size for exosome diagnostics and therapy is projected to witness a significant surge over the coming years, reaching $1.62 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 28.0%. Factors such as increasing clinical applications, digital health technology integration, favourable regulatory conditions, developments in RNA therapeutics and gene editing, and a heightened role in immuno-oncology are contributing to this growth witnessed in the forecast period. During the forecast timeline, key trends are anticipated to include drug discovery based on exosomes, biomimetic exosome engineering, commercialisation of exosome-related products, therapeutic cargo loaded with exosomes, and liquid biopsy employed for cancer screening.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12346&type=smp
What Are the Core Growth Drivers Propelling the Exosome Diagnostic And Therapeutic Market Forward?
The increasing incidence of chronic illnesses is anticipated to boost the expansion of the exosome diagnostic and therapeutic market. Chronic diseases, which are conditions that persist for at least three months and may worsen over time, are central to this prediction. In cancer, exosomes utilized in diagnosis and therapy serve as potential biomarkers, enabling more precise disease tracking and making individualized medicine more accessible. For example, the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, predicted in January 2023 that by 2050 there will be 142.66 million people suffering from chronic diseases globally. Consequently, the upsurge in chronic illnesses is fuelling the growth of the exosome diagnostics and therapeutics market.
What Segment Types Define the Exosome Diagnostic And Therapeutic Market Structure?
The exosome diagnostic and therapeuticmarket covered in this report is segmented –
1) By Product: Instruments, Software, Reagents And Kits
2) By Application: Diagnostics, Therapeutic
3) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Clinics, Other End Users
Subsegments:
1) By Instruments: Exosome Isolation Systems, Characterization Instruments, Analysis Devices
2) By Software: Data Analysis Software, Exosome Profiling Software, Laboratory Management Software
3) By Reagents And KITS: Isolation KITS, Characterization Reagents, Assay KITS
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=12346&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Exosome Diagnostic And Therapeutic Market?
North America was the largest region in the exosome diagnostic and therapeutic market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the exosome diagnostic and therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Which Emerging Trends that Are Influencing theExosome Diagnostic And Therapeutic Industry Evolution?
In order to reach a broader client base, boost sales, and raise revenue, leading companies in the exosome diagnostic and therapeutic market are making strides in product innovation, particularly in the development of sample purification systems. These systems leverage a variety of methods and technologies to remove unwanted elements like DNA, RNA, proteins, and other biomolecules from a sample. For example, Biological Dynamics Inc., a US biotechnology firm, introduced ExoVerita, an exosome-isolation platform for early disease monitoring and other uses, in February 2023. The ExoVita Pancreas assay, which utilizes this platform, detects specific exosomal protein markers and is capable of identifying Stage 1 and Stage 2 pancreatic ductal adenoma carcinoma (PDAC) in blood-based exosome samples processed through the patented ExoVerita device. Biological Dynamics will use this validation phase to evaluate samples from the ExoLuminate registry trial (NCT05625529), which is now recruiting high-risk PDAC patients to assess the test’s medical relevance. Individuals displaying symptoms like pancreatitis or confirmed pancreatic abnormalities, those with a genetic or family history, and newly diagnosed diabetics over the age of 50 are among the eligible participants.
View the full report here:
What Is the Definition of the Exosome Diagnostic And Therapeutic Market?
Exosome diagnostics and therapeutic refer to using exosomes, tiny extracellular particles generated by cells, in diagnosis and therapy. Exosomes are used in exosome therapies as a method of targeted medication delivery for regenerative medicine.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12346
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
